NIH Funding Announcements
BIOENGINEERING RESEARCH GRANTS (BRG)(R01)(MULTIPLE ICS INCLUDING NCI) (PA-10-009)
Application Receipt Dates: Standard dates apply
Participating Institutes and Centers invite applications for R01 awards to support Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological, bioengineering or medical research problems. The BRGs support multi-disciplinary research performed in a single laboratory or by a small number of investigators that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. A BRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research.
NATIONAL CENTERS FOR BIOMEDICAL COMPUTING (U54)(MULTIPLE ICS INCLUDING NCI) (RFA-RM-09-002)
Letters of Intent Receipt Date: December 9, 2009
Application Receipt Date: January 8, 2010
This FOA issued under the NIH Common Fund solicits grant applications that propose to continue the NIH National Centers for Biomedical Computing (NCBC) program. These Centers, in conjunction with individual investigator awards, are creating a networked effort to build the computational infrastructure for biomedical computing in the nation.
TECHNOLOGIES FOR IMAGE-GUIDED INTERVENTIONS (R01) (NIBIB) (RFA-EB-09-002)
Letter of Intent Receipt Date: December 20, 2009
Application Due Date: January 10, 2010
This FOA solicits research project grant (R01) applications that propose high-impact technologies for image-guided interventions. This FOA is intended to support the second phase of a two-phase project that will deliver image-guided interventions that have a high clinical impact. Preliminary data describing a prototype system that demonstrates the feasibility of the image-guided intervention is required to apply to this solicitation. Multidisciplinary collaborations and/or partnerships with industry are encouraged, but are not required. In addition, development of technology platforms that might have applicability across a range of clinical conditions are suitable. Reminder: The Research Plan may not exceed 13 pages. No renewals or resubmissions are allowed.
NIBIB QUANTUM PROJECTS: IMPLEMENTATION PHASE II (U01)(NIBIB)(RFA-EB-09-003)
Receipt Date: December 22, 2009
Application Due Date: January 22, 2010
The goal of the NIBIB Quantum Grant program is to achieve a profound (quantum) advance over present-day approaches in the prevention, diagnosis, or treatment of a major disease or national public health problem (i.e., leading categories of disease burden, high-mortality/morbidity diseases affecting more than 100,000 individuals annually, technologies that revolutionize over 200,000 procedures annually). This announcement for Phase II Quantum applications will support multi-investigator, multi-disciplinary teams that propose to address all remaining obstacles that must be removed to advance the target technology to clinical testing to demonstrate practical significance within the Phase II award period and produce data to support initial realization of a quantum advance. Phase II will support continued engineering and development of the technologies necessary to conduct initial clinical studies, and produce initial data demonstrative of a quantum impact on healthcare by the end of Phase II or that such an impact is expected.
ANNOUNCING THE TRANSITION OF INSTITUTIONAL TRAINING AND INSTITUTIONAL CAREER DEVELOPMENT PROGRAMS TO ELECTRONIC SUBMISSION FOR DUE DATES ON/AFTER JANUARY 25, 2010 (NOT-OD-10-008)
Applications for Institutional Training and Institutional Career Development Programs will transition to electronic submission through Grants.gov using the SF424 (R&R) forms for due dates on or after January 25, 2010. The following programs will transition:
ALL applications in response to announcements for these grant programs must be submitted electronically (paper applications will not be accepted). Applications first submitted in paper that are being resubmitted as amended applications must now use electronic submission via Grants.gov using the SF424 (R&R) forms. Funding Opportunity Announcements (FOAs) for these programs are being updated and are expected to be posted by November 25, 2009.
CIP DCIDE PROGRAM MORPHS INTO NExTThe Cancer Imaging Program's DCIDE program for providing data to investigators for their IND filings is being absorbed by the NCI Experimental Therapeutics Program (NExT). On the web site, click on the NExT icon to start submission of a NExT application. The first round of submissions are due September 15, 2009, and quarterly after that starting November 15, 2009. Click on the instructions to see what you need to do to apply. The reviews are to be handled by outside Special Emphasis Panels empanelled for the purpose.
GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE
The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at email@example.com. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
RSNA 95th Scientific Assembly
November 29- December 4, 2009, McCormick Place, Chicago, IL
RSNA 2010 Clinical Trials Methodology Workshop
January 9-15, 2010, Hyatt Regency, Scottsdale, Arizona
Apply on line by June 8, 2009.
RSNA Writing a Competitive Grant Proposal Program
January 29-30, 2010, RSNA Headquarters, Oak Brook, Illinois
Deadline for application: December 15, 2009
SPIE Medical Imaging Conference
February 13 - 18, 2010, Town & Country Resort & Convention Center, San Diego, California
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (firstname.lastname@example.org). Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program,
Division of Cancer Treatment and Diagnosis,
NCI 6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507